dc.contributor.author | Rahimzadeh, A | |
dc.contributor.author | Farajnia, S | |
dc.contributor.author | Pourbabaee, AA | |
dc.contributor.author | Ansarin, K | |
dc.contributor.author | Zolfaghari, MR | |
dc.contributor.author | Masoudi, N | |
dc.date.accessioned | 2018-08-26T08:51:32Z | |
dc.date.available | 2018-08-26T08:51:32Z | |
dc.date.issued | 2012 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53435 | |
dc.description.abstract | Background and objective: Acinetobacter (A.) baumannii is a gram-negative non-fermentative coccobacilli with increasing relevance in a variety of hospital-acquired infections. The aim of this study was to determine the frequency of bla-OXA-2 and bla-OXA-10 resistance genes and class I Integron among Acinetobacter baumannii strains isolated from patients referred to Imam Reza hospital of Tabriz city, Iran. Methods: This cross-sectional descriptive study was carried out on 100 Acinetobacter baumannii isolated from patients referred to Imam Reza hospital of Tabriz, Iran in 2009-2010. The isolates were identified using standard biochemical and microbiological tests. ESBL production was determined in isolates by Combined Disc test. The presence of bla-OXA-10, bla-OXA-2 and INT-1 genes in clinical isolates was investigated by PCR technique. Findings: The results of antimicrobial sensitivity tests revealed that the highest resistance was against cefixime (100%), ceftizoxime (100%) and ticaracilin (100%), whereas the highest susceptibility was observed for polymyxin B (84%), colistin (77%) and rifampin (73%). Combined Disc Test showed that 60% of isolated were ESBL producer among them 7 cases (11.6%) were positive for bla-OXA-2 and 5 cases (8.3%) for bla-OXA-10 genes. Screening for INT-1 genes demonstrated that 73% of isolates were positive for Int-1 insertion sequence. Conclusion: The results of this study showed the presence of OXA-2 and OXA-10 type ESBLs and class I integron genes among drug resistant Acinetobacter strains that reminding the necessity of preventive measures for inhibiting dissemination of these resistant isolates. | |
dc.language.iso | Persian | |
dc.relation.ispartof | Journal of Babol University of Medical Sciences | |
dc.subject | cefixime | |
dc.subject | ceftizoxime | |
dc.subject | colistin | |
dc.subject | polymyxin B | |
dc.subject | rifampicin | |
dc.subject | ticarcillin | |
dc.subject | Acinetobacter baumannii | |
dc.subject | antibiotic sensitivity | |
dc.subject | Article | |
dc.subject | bacterial gene | |
dc.subject | bacterial strain | |
dc.subject | bacterium isolation | |
dc.subject | cross-sectional study | |
dc.subject | extended spectrum beta lactamase OXA 10 | |
dc.subject | extended spectrum beta lactamase OXA 2 | |
dc.subject | gene frequency | |
dc.subject | human | |
dc.subject | integron 1 gene | |
dc.subject | Iran | |
dc.subject | nonhuman | |
dc.subject | polymerase chain reaction | |
dc.title | Detection of prevalence of OXA-2 and OXA-10 type ESBL and class I Integron among Acinetobacter bumanii strains isolated from patients of Tabriz City (Iran) by PCR technique | |
dc.type | Article | |
dc.citation.volume | 14 | |
dc.citation.issue | 5 | |
dc.citation.spage | 56 | |
dc.citation.epage | 63 | |
dc.citation.index | Scopus | |